Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059234) titled 'Single-center prospective observational study investigating the impact of beta1 adrenergic receptor and its auto-antibody on responsiveness of beta-blocker in heart failure therapy' on Sept. 29.

Study Type: Observational

Study Design: Not selected Not selected

Primary Sponsor: Hamamatsu University School of Medicine

Condition: heart failure

Recruitment Status: Recruiting

Phase: Not selected

Date of First Enrollment: 2024/08/01

Target Sample Size: 100

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067752

Published by HT D...